Skip to main content

Find Clinical Trials

Home
Conditions
Hypothalamic Diseases

Clinical trial condition

Hypothalamic Diseases

Explore clinical trials studying Hypothalamic Diseases. Study availability and eligibility vary by location and protocol.

589 public trials 88 recruiting studies

Refine in advanced search Browse all conditions

Hypothalamic Diseases trial results

Completed

Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome

NCT00565903

Conditions: Adnexal Diseases, Brain Diseases, Brain Neoplasms, +60 more
Locations: Children's National Medical Center Washington D.C., District of Columbia, United States

View Trial Details

Completed

Effect of Protein Supplementation on Plasma Sodium Levels and Urinary Urea Excretion in Patients With SIAD

NCT04987385

Conditions: Brain Diseases, Central Nervous System Diseases, Endocrine System Diseases, +9 more
Locations: University Hospital Basel, Department of Endocrinology Basel, Switzerland

View Trial Details

Completed

Long-Acting Growth Hormone in Children Compared to Daily rhGH

NCT02339090

Conditions: Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +15 more
Locations: Not specified

View Trial Details

Completed

Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?

NCT02152124

Conditions: Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +13 more
Locations: Ghent University Hospital, Department of Endocrinology, 9K12IE Ghent, Belgium

View Trial Details

Completed

Transnasal Endoscopic Pituitary Surgery - the Effect of Posterior Nasal Septum Resection on Nasal Functions

NCT04782596

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +13 more
Locations: University Hospital Ostrava Ostrava, Moravian-Silesian Region, Czechia

View Trial Details

Completed

Changes in the Hypotalamic-pituitary Region of Patients With Metabolic Syndrome and Obesity

NCT03458533

Conditions: Body Weight, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Andrea M Isidori Rome, Italy

View Trial Details

Completed

Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

NCT03548415

Conditions: Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations: University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States

St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

Northwestern University Chicago, Illinois, United States

Palm Research Center, Inc. Las Vegas, Nevada, United States

View all 33 locations

View Trial Details

Completed

Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment

NCT04002258

Conditions: Antipyretics Toxicity, Brain Diseases, Central Nervous System Diseases, +10 more
Locations: Shanghai Mental Health Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma

NCT00690898

Conditions: Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations: University Hospital Antwerpen Edegem, Belgium

Všeobecná fakultní nemocnice, Karlova Univerzita Prague, Czechia

Helsinki University Center Hospital Helsinki, Finland

The Turku University Central Hospital Turku, Finland

View all 27 locations

View Trial Details

Completed

Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients

NCT00383708

Conditions: Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations: University Hospital, Charles University Hradec Králové, Czechia

Charles University Prague, Czechia

Aarhus Kommunehospital Aarhus, Denmark

Groupe Hospitalier Henri Mondor- Albert Chenevier Créteil, France

View all 24 locations

View Trial Details